cont.
Is there still value in SYR and what are the risks?
Today's share price move (-13%) in our view reflects a revision to pricing expectations
as the market tries to determine a sustainable long term price. The UBS LT basket price
is US$824/t and we see the market today pricing in less than US$600/t (assuming no value for
BAM). Commercial production was declared from 1 Jan 19. Q1 19 net cash outflows
are forecast at US$20.4m with first positive cash flow on a C1 basis from Q2 19 (prev.
Q1 19). However, with net outflows this half likely to take the cash balance below
US$50m, we think attention will return to the need for a debt facility. SYR continue to
reiterate the key to achieving this will be production consistency and pricing certainty.
Valuation: A$2.64ps (prev. A$2.87ps) DCF @ 13% d.r.
We lower our PT to A$2.65ps (prev. A$2.90ps), set in line with NPV (unch). We retain
our Buy rating but caution share price performance is likely to hinge on confidence in
price lifting and achieving positive FCF.
- Forums
- ASX - By Stock
- One step forward but two steps back
cont. Is there still value in SYR and what are the risks?...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SYR (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $232.8M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 25.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.0¢ | 2000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 116062 | 1.070 |
10 | 209299 | 1.065 |
8 | 106613 | 1.060 |
6 | 96647 | 1.055 |
10 | 132219 | 1.050 |
Price($) | Vol. | No. |
---|---|---|
1.075 | 58078 | 4 |
1.080 | 70753 | 4 |
1.085 | 72117 | 5 |
1.090 | 103210 | 6 |
1.095 | 57928 | 2 |
Last trade - 09.40am 25/11/2024 (20 minute delay) ? |
Featured News
SYR (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online